PRO-DEX INC (PDEX) Stock Fundamental Analysis
NASDAQ:PDEX - Nasdaq - US74265M2052 - Common Stock - Currency: USD
PDEX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. PDEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PDEX is evaluated to be cheap and growing strongly. This does not happen too often! These ratings could make PDEX a good candidate for value and growth and quality investing.
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a positive operating cash flow in the past year.
PDEX had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 11.18%, PDEX belongs to the best of the industry, outperforming 93.12% of the companies in the same industry.
PDEX has a better Return On Equity (21.21%) than 94.18% of its industry peers.
With an excellent Return On Invested Capital value of 18.51%, PDEX belongs to the best of the industry, outperforming 97.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PDEX is above the industry average of 7.71%.
The 3 year average ROIC (11.81%) for PDEX is below the current ROIC(18.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROIC | 18.51% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
1.3 Margins
With an excellent Profit Margin value of 11.06%, PDEX belongs to the best of the industry, outperforming 86.77% of the companies in the same industry.
PDEX's Profit Margin has declined in the last couple of years.
PDEX's Operating Margin of 16.83% is amongst the best of the industry. PDEX outperforms 89.42% of its industry peers.
In the last couple of years the Operating Margin of PDEX has declined.
With a Gross Margin value of 30.02%, PDEX is not doing good in the industry: 75.66% of the companies in the same industry are doing better.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% |
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PDEX is creating value.
The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
Compared to 1 year ago, PDEX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.91 indicates that PDEX is not in any danger for bankruptcy at the moment.
The Altman-Z score of PDEX (5.91) is better than 82.01% of its industry peers.
The Debt to FCF ratio of PDEX is 10.01, which is on the high side as it means it would take PDEX, 10.01 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 10.01, PDEX is doing good in the industry, outperforming 73.55% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that PDEX is not too dependend on debt financing.
PDEX's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. PDEX outperforms 48.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Altman-Z | 5.91 |
ROIC/WACC2.16
WACC8.57%
2.3 Liquidity
PDEX has a Current Ratio of 2.58. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX's Current ratio of 2.58 is in line compared to the rest of the industry. PDEX outperforms 48.15% of its industry peers.
PDEX has a Quick Ratio of 1.44. This is a normal value and indicates that PDEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.44, PDEX is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 382.76% over the past year.
Measured over the past years, PDEX shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.76% on average per year.
Looking at the last year, PDEX shows a quite strong growth in Revenue. The Revenue has grown by 16.82% in the last year.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.66% yearly.
EPS 1Y (TTM)382.76%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%415.79%
Revenue 1Y (TTM)16.82%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%21.81%
3.2 Future
The Earnings Per Share is expected to grow by 97.88% on average over the next years. This is a very strong growth
Based on estimates for the next years, PDEX will show a quite strong growth in Revenue. The Revenue will grow by 19.04% on average per year.
EPS Next Y278.39%
EPS Next 2Y97.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year37.45%
Revenue Next 2Y19.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.00, PDEX is valued correctly.
PDEX's Price/Earnings ratio is rather cheap when compared to the industry. PDEX is cheaper than 82.01% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.29. PDEX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 18.45, the valuation of PDEX can be described as rather expensive.
PDEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PDEX is cheaper than 79.89% of the companies in the same industry.
PDEX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | 18.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 81.48% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PDEX is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.22 | ||
| EV/EBITDA | 13.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PDEX may justify a higher PE ratio.
A more expensive valuation may be justified as PDEX's earnings are expected to grow with 97.88% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y97.88%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PDEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PDEX (5/6/2025, 8:00:00 PM)
44.8
-0.14 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.57%
Inst Owner Change0.08%
Ins Owners36.12%
Ins Owner Change2.38%
Market Cap146.05M
Analysts82.86
Price Target55.08 (22.95%)
Short Float %4.82%
Short Ratio2.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.46%
Min EPS beat(2)57.38%
Max EPS beat(2)153.55%
EPS beat(4)3
Avg EPS beat(4)48.25%
Min EPS beat(4)-46.78%
Max EPS beat(4)153.55%
EPS beat(8)5
Avg EPS beat(8)5.08%
EPS beat(12)6
Avg EPS beat(12)4.21%
EPS beat(16)7
Avg EPS beat(16)8.33%
Revenue beat(2)2
Avg Revenue beat(2)19.98%
Min Revenue beat(2)19.3%
Max Revenue beat(2)20.66%
Revenue beat(4)4
Avg Revenue beat(4)21.27%
Min Revenue beat(4)6.16%
Max Revenue beat(4)38.97%
Revenue beat(8)7
Avg Revenue beat(8)14.81%
Revenue beat(12)10
Avg Revenue beat(12)12.67%
Revenue beat(16)13
Avg Revenue beat(16)13.18%
PT rev (1m)0%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.3%
EPS NY rev (1m)0%
EPS NY rev (3m)15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | 18.45 | ||
| P/S | 2.39 | ||
| P/FCF | 89.22 | ||
| P/OCF | 51.53 | ||
| P/B | 4.59 | ||
| P/tB | 4.6 | ||
| EV/EBITDA | 13.33 |
EPS(TTM)2.8
EY6.25%
EPS(NY)2.43
Fwd EY5.42%
FCF(TTM)0.5
FCFY1.12%
OCF(TTM)0.87
OCFY1.94%
SpS18.71
BVpS9.76
TBVpS9.75
PEG (NY)0.06
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROCE | 23.75% | ||
| ROIC | 18.51% | ||
| ROICexc | 20.78% | ||
| ROICexgc | 20.8% | ||
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% | ||
| FCFM | 2.68% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
ROICexc(3y)13.33%
ROICexc(5y)16.93%
ROICexgc(3y)13.36%
ROICexgc(5y)17.03%
ROCE(3y)15.15%
ROCE(5y)17.2%
ROICexcg growth 3Y11.8%
ROICexcg growth 5Y-12.49%
ROICexc growth 3Y11.98%
ROICexc growth 5Y-12.32%
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 99.17% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 16.54 | ||
| Cash Conversion | 24.7% | ||
| Profit Quality | 24.26% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 5.91 |
F-Score6
WACC8.57%
ROIC/WACC2.16
Cap/Depr(3y)140.73%
Cap/Depr(5y)342.39%
Cap/Sales(3y)2.61%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.76%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%415.79%
EPS Next Y278.39%
EPS Next 2Y97.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.82%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%21.81%
Revenue Next Year37.45%
Revenue Next 2Y19.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.34%
EBIT growth 3Y16.56%
EBIT growth 5Y7.53%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.74%
FCF growth 3YN/A
FCF growth 5Y22%
OCF growth 1Y210.27%
OCF growth 3YN/A
OCF growth 5Y13.23%